Drug factory · FDA FEI 3003882011

Quotient Sciences - Philadelphia, LLC

3 Chelsea Pkwy Ste 305, Boothwyn, PA, United States

United States: 1

Problems found, fixed voluntarily at FDA's last inspection, Sep 17, 2025.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

7 drug inspections on record since 2010: 3 with no problems, 4 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
TovorafenibMakes it Day One Biopharmaceuticals, Inc. 82950-001, 82950-012

FDA inspection history

EndedResultProgramProblems noted
Sep 17, 2025Problems found, fixed voluntarilyDrug Quality Assurance3
Dec 22, 2022Problems found, fixed voluntarilyDrug Quality Assurance1
Nov 6, 2017Problems found, fixed voluntarilyDrug Quality Assurance—
Nov 2, 2015Problems found, fixed voluntarilyDrug Quality Assurance—
Nov 7, 2013No problems foundDrug Quality Assurance—
Jan 12, 2012No problems foundDrug Quality Assurance—
Sep 9, 2010No problems foundDrug Quality Assurance—

What inspectors wrote down

From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.

Sep 17, 2025 inspection

Dec 22, 2022 inspection

Registered with FDA for: analysis; manufacture.